Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Denali Therapeutics
Denali Therapeutics
Biogen buys into Denali’s amyloid beta program
Biogen buys into Denali’s amyloid beta program
Pharmaphorum
Biogen
Denali Therapeutics
Alzheimer's disease
Flag link:
Why Denali Therapeutics' Stock Rose 6.6% on Wednesday
Why Denali Therapeutics' Stock Rose 6.6% on Wednesday
Motley Fool
Denali Therapeutics
clinical trials
Alzheimer's disease
TAK-594
Flag link:
Biogen, Denali begin late-stage testing of Parkinson’s drug
Biogen, Denali begin late-stage testing of Parkinson’s drug
BioPharma Dive
Biogen
Denali Therapeutics
Parkinson's Disease
clinical trials
BIIB122
Flag link:
Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2022
Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2022
BioSpace
Denali Therapeutics
clinical trials
DNL310
Hunter Syndrome
Flag link:
Denali Receives Formal Letter Regarding FDA Hold On Alzheimer's Potential Program
Denali Receives Formal Letter Regarding FDA Hold On Alzheimer's Potential Program
Benzinga
Denali Therapeutics
FDA
DNL919
clinical hold
Alzheimer's disease
Flag link:
FDA denies Denali's Takeda-partnered Alzheimer's drug from entering clinic
FDA denies Denali's Takeda-partnered Alzheimer's drug from entering clinic
Fierce Biotech
Denali Therapeutics
Takeda
Alzheimer's disease
FDA
DNL919
Flag link:
Denali Moving Forward with Sanofi-Partnered ALS Candidate
Denali Moving Forward with Sanofi-Partnered ALS Candidate
BioSpace
Denali Therapeutics
Sanofi
ALS
DNL343
clinical trials
Flag link:
Denali Therapeutics Sees Positive Data in Trial for Enzyme Replacement Therapy
Denali Therapeutics Sees Positive Data in Trial for Enzyme Replacement Therapy
Marketwatch
Denali Therapeutics
DNL310
enzymes
Hunter Syndrome
clinical trials
Flag link:
Biden's Budget May Boost These 3 Biotechs
Biden's Budget May Boost These 3 Biotechs
Motley Fool
Joe Biden
Alzheimer's disease
Denali Therapeutics
Cassava Sciences
Eli Lilly
Flag link:
A safer Alzheimer's drug than Biogen's aducanumab? Denali-WashU drug shows better profile in mice
A safer Alzheimer's drug than Biogen's aducanumab? Denali-WashU drug shows better profile in mice
Fierce Biotech
Alzheimer's disease
Denali Therapeutics
Biogen
aducanumab
HAE-4
Flag link:
Denali unveils first proof-of-concept for brain delivery tech in rare disease, with eyes on much bigger indications
Denali unveils first proof-of-concept for brain delivery tech in rare disease, with eyes on much bigger indications
Endpoints
Denali Therapeutics
Hunter Syndrome
proof-of-concept
Flag link:
Denali Therapeutics stock rockets into record territory after Biogen investment and collaboration
Denali Therapeutics stock rockets into record territory after Biogen investment and collaboration
Marketwatch
Denali Therapeutics
Biogen
Parkinson's Disease
Flag link:
After Disappointing Study Results, Denali and Sanofi Shift Resources to a Different Alzheimer's Drug
After Disappointing Study Results, Denali and Sanofi Shift Resources to a Different Alzheimer's Drug
BioSpace
Denali Therapeutics
Sanofi
DNL747
ALS
Alzheimer's disease
DNL788
clinical trials
Flag link:
Denali scoots past a setback with barely a scratch, quickly calling up a backup Alzheimer’s player on the bench
Denali scoots past a setback with barely a scratch, quickly calling up a backup Alzheimer’s player on the bench
Endpoints
Denali Therapeutics
Genentech
DNL747
Flag link:
Denali unveils new way of crossing blood brain barrier as the big neuroscience bets enter its clinical years
Denali unveils new way of crossing blood brain barrier as the big neuroscience bets enter its clinical years
Endpoints
Denali Therapeutics
Neurosciences
blood-brain barrier
Flag link:
Big Pharma Has Mad Love For These 2 Biotechs
Big Pharma Has Mad Love For These 2 Biotechs
Motley Fool
Big Pharma
biotechs
Regenxbio
Denali Therapeutics
Flag link:
Where Are They Now? Top 3 Biotech Startups From NextGen Bio Class of 2017
Where Are They Now? Top 3 Biotech Startups From NextGen Bio Class of 2017
BioSpace
Denali Therapeutics
C4 Therapeutics
Neon Therapeutics
Flag link:
JP Morgan Healthcare Conference Update: Sage, Mersana, Shutdown Woes and Babies
JP Morgan Healthcare Conference Update: Sage, Mersana, Shutdown Woes and Babies
BioSpace
JPMHC 2019
SAGE Therapeutics
SAGE-217
Mersana
Novavax
Denali Therapeutics
AstraZeneca
Amarin
FDA
government shutdown
Flag link:
Sanofi Pledges $125M to Denali in Pact for Neuro, Inflammation Drugs
Sanofi Pledges $125M to Denali in Pact for Neuro, Inflammation Drugs
Xconomy
Sanofi
Denali Therapeutics
inflammation
Alzheimer's disease
R&D
Flag link:
Milestone Moment: A Parkinson’s Drug Moves Forward With Help From Michael J.Fox
Milestone Moment: A Parkinson’s Drug Moves Forward With Help From Michael J.Fox
Forbes
Denali Therapeutics
Michael J Fox
Parkinson's Disease
Flag link:
Pages
1
2
next ›
last »